Kehinde S Olaniyi
Kehinde S Olaniyi is an expert in Pharmacy at Afe Babalola University (Nigeria). As of September 2026, ScienceLeadR ranks Kehinde S Olaniyi in the top 1% of experts in Nigeria for Adnexal Diseases and Gonadal Disorders. Kehinde S Olaniyi has authored 123 publications, the most recent in 2026. SLR score: 451 (community average: 125). How the SLR is computed.
LeadR Profile
Pharmacy
Subspecialties: Cardiology - Biochemistry - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2016 - 2026
Number : 123
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Comparison of Clotting and Inflammatory Biomarkers Between Young Hypertensive and Normotensive Adults in Ekiti State, Nigeria. PMID 42676705 — hypertension, uric acid, antithrombins, antithrombin iii, biomarkers, aged, fibrinogen, interleukin-33, lipoprotein(a), bilirubin | Niger Med J | 2026 | 0 |
| Experimental Evaluation of Sorbitol's Impact on the Testicular Axis in Male Wistar Rats. PMID 42537038 — physiology, sorbitol, serum, sperm count, testosterone, spermatozoa | Niger J Physiol Sci | 2026 | 0 |
| Impact of plant-based interventions on gynecological cancers: a narrative review of mechanistic interplays and clinical evidence. PMID 42416332 — biological availability, uterine cervical neoplasms, ovary, neoplasms, terpenes, drug therapy, apoptosis, phytochemicals, endometrial neoplasms, chemotherapy | Front Mol Med | 2026 | 0 |
| Sleep deprivation impairs gastric ulcer healing and induces anxiety-like behavior in rats. PMID 42399736 — sleep deprivation, biomedical research, sleep, stress, physiological, ulcer, stomach ulcer, oxidative stress, antioxidants | BMC Res Notes | 2026 | 0 |
| Telomere-driven dysfunctional changes in gynecological cancers: mechanistic insights, biomarker potential, and therapeutic targeting. PMID 42317265 — neoplasms, telomerase, biomarkers, maintenance, genomic instability, therapeutics, telomere | Front Cell Dev Biol | 2026 | 0 |
LeadR Networks
Main global connection map